Skip to main content

Find Clinical Trials

Home
Conditions
Lung Adenocarcinoma EGFR-mutated/ ALK Traslocation

Clinical trial condition

Lung Adenocarcinoma EGFR-mutated/ ALK Traslocation

Explore clinical trials studying Lung Adenocarcinoma EGFR-mutated/ ALK Traslocation. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Lung Adenocarcinoma EGFR-mutated/ ALK Traslocation trial results

Active, Not Recruiting

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

NCT04802876

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +111 more
Locations: Grupo SOLTI Barcelona, Spain

View Trial Details